Reference
Uskudar Cansu D, et al. Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data. Journal of the National Medical Association 111: 262-269, No. 3, Jun 2019. Available from: URL: http://doi.org/10.1016/j.jnma.2018.10.003 - Turkey
Rights and permissions
About this article
Cite this article
Adalimumab/etanercept/infliximab. Reactions Weekly 1763, 23 (2019). https://doi.org/10.1007/s40278-019-65115-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-65115-y